Speaking of ages, middle-aged and senile HCC patients (41–80 years old) tended to have higher expression levels of CXCL9/10, compared with those in youth (21–40 years old) (P<0.05) (Figure 2B). Here, CXCL9 is linked to hepatocellular carcinoma.